Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats

Table 2

Example of cut-off for therapy (a) decrease in localised cHL, (b) increase in advanced cHL.

(a)

(1) No uptake
(2) Uptake ≤ mediastinum
(3) Uptake > mediastinum but ≤ liver
(4) Uptake moderately more than liver uptake, at any site
(5) Markedly increased uptake at any site and new site of
disease.

(b)

(1) No uptake
(2) Uptake ≤ mediastinum
(3) Uptake > mediastinum but ≤ liver
(4) Uptake moderately more than liver uptake, at any site
(5) Markedly increased uptake at any site and new site of
disease.